A 3- to 5-day Clinical Trial of Levamisole in Loiasis Infected Subjects
Status:
RECRUITING
Trial end date:
2026-02-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate the safety and efficacy of a 3- and 5-day course of levamisole (2.5 mg/kg) in management of loiasis microfilaremia.
Phase:
PHASE2
Details
Lead Sponsor:
Programme National de Lutte contre l'Onchocercose, Republic of the Congo